EFFECTIVENESS AND SAFETY OF IBRUTINIB IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND MANTLE CELL LYMPHOMA (MCL) IN BELGIAN ROUTINE CLINICAL PRACTICE WITH A 3‐YEAR FOLLOW‐UP

Autor:	B. De Beleyr, Z. Berneman, Fritz Offner, R. Wapenaar, A. Smet, Marc André, C. Van Bogaert, S. Snauwaert, Dominique Bron, Ann Janssens, L Nielsen
Rok vydání:	2021
Předmět:	Oncology Cancer Research medicine.medical_specialty business.industry Chronic lymphocytic leukemia Hematology General Medicine medicine.disease chemistry.chemical_compound chemistry Ibrutinib Internal medicine medicine Mantle cell lymphoma Routine clinical practice business
Zdroj:	Hematological Oncology. 39
ISSN:	1099-1069 0278-0232
DOI:	10.1002/hon.20_2881
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::60e9a402eb079e1f17e49a28ec1af835 https://doi.org/10.1002/hon.20_2881 Zobrazit plný text záznamu Plný text